New project: "Systems-based Therapy of AML Stem Cells (SyTASC)"

Within the consortium entitled „Systems-based Therapy of AML Stem Cells (SyTASC)“, which is funded by the Deutsche Krebshilfe, clinicians, biologist, bioinformaticians and mathematicians will work together to better understand the reasons for good or bad treatment response of patients with acute myeloid leukaemia (AML). The project will start in summer 2016.